NMS · Biotechnology

HOWL (HOWL) Stock

$0.40 -3.04% NMS: HOWL Healthcare

Valuation

MetricValue
Price$0.40
Market Cap$19.54M
P/E Ratio-0.33
P/B Ratio0.85
P/S Ratio0.00
EPS (TTM)$-1.33
52-Week High$2.38
52-Week Low$0.30
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-244.00%
ROA-88.41%
ROCE-254.17%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity3.09
Current Ratio1.64

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$16.0M$20.0M$2.0M$0
Operating Profit$-50.0M$-56.0M$-41.0M$-74.0M$-61.0M
Net Profit$-50.0M$-54.0M$-37.0M$-71.0M$-61.0M
EPS$-10.94$-1.86$-1.05$-1.63$-1.33
Op Margin—-341.8%-203.1%-3904.2%—

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$179.0M$160.0M$175.0M$127.0M$69.0M
Total Liabilities$26.0M$38.0M$63.0M$54.0M$45.0M
Cash$158.0M$129.0M$134.0M$111.0M$58.0M
Borrowings$16.0M$15.0M$52.0M$37.0M$9.0M

Latest News

Here's Why We're A Bit Worried About Werewolf Therapeutics' (NASDAQ:HOWL) Cash Burn Situation Simply Wall St. · May 14, 2026 Werewolf Therapeutics Insider Sold Shares Worth $280,210, According to a Recent SEC Filing MT Newswires · May 13, 2026 Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates GlobeNewswire · May 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-43.0M$-41.0M$-33.0M$-56.0M$-60.0M
Investing Cash Flow$-1.0M$-7.0M$-2.0M$-1.0M$0
Financing Cash Flow$-2.0M$0$0$0$0
Net Cash Flow$66.0M$-28.0M$25.0M$-43.0M$-54.0M
Free Cash Flow$-43.0M$-44.0M$-33.0M$-56.0M$-60.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-244.02%
Quick Ratio1.27
Interest Coverage-12.20
Return 1Y-74.08%
Return 3Y-89.26%
Return 5Y-97.86%

Ownership

Insiders Held5.61%
Institutions Held26.71%
Institutions Float Held28.30%
Institutional HolderSharesReport Date
RA Capital Management, L.P.6,681,3072026-03-31
Vanguard Capital Management LLC1,217,9762026-03-31
MPM Bioimpact LLC1,208,8102026-03-31
Lynx1 Capital Management Lp657,7862026-03-31
Sphera Funds Management Ltd.626,8102026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACET $8.30 +1.22% -0.46 $77.59M 0.00%
CUE $32.57 +1.40% -4.05 $85.59M 0.00%
INMB $1.73 +6.79% -2.44 $45.99M 0.00%
IOBTIO Biotech, Inc. $0.01 -27.59% -0.01 $885690 0.00%
LITS $0.91 -2.31% -0.35 $30.88M 0.00%

About HOWL

HOWL is led by CEO Daniel J. Hicklin, employs 46 people, headquartered in US, publicly traded since 2021.

HOWL stock trades at $0.40 with a market capitalization of $19.54M. The stock is valued at a price-to-earnings (P/E) ratio of -0.33, price-to-book of 0.85, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.30 and $2.38, and currently trades 83.2% below its 52-week high.

On profitability, HOWL generates a return on equity (ROE) of -244.00%, return on capital employed of -254.17%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides